Is Gujarat Themis Biosyn Ltd (GUJTHEM) a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Gujarat Themis Biosyn Ltd is a good quality company .

Is Gujarat Themis Biosyn Ltd (GUJTHEM) undervalued or overvalued?

The key valuation ratios of Gujarat Themis Biosyn Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone .

What is Gujarat Themis Biosyn Ltd (GUJTHEM) share price return in the past 10 years?

Gujarat Themis Biosyn Ltd share price has appreciated 46.9% annually (CAGR) over the past ten years.

Is Gujarat Themis Biosyn Ltd (GUJTHEM) a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Strong which suggest that the price of Gujarat Themis Biosyn Ltd is likely to Rise in the short term. However, please check the rating on Quality and Valuation before investing

What is the share price of Gujarat Themis Biosyn Ltd (GUJTHEM)?

Company share prices are keep on changing according to the market conditions. The current trading price of Gujarat Themis Biosyn Ltd (GUJTHEM) on 17-Apr-2026 16:59:59 at 16:59 is 319.45.

What is the market cap of Gujarat Themis Biosyn Ltd (GUJTHEM)?

Market capitalization is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 17-Apr-2026 at 16:59, the market cap of Gujarat Themis Biosyn stood at Rs. 3480.90 Cr.

What is the P/E ratio of Gujarat Themis Biosyn?

The latest standalone P/E ratio of Gujarat Themis Biosyn as of 17-Apr-2026 is 72.84.

What is the P/B ratio of Gujarat Themis Biosyn Ltd (GUJTHEM)?

The latest standalone P/B ratio of Gujarat Themis Biosyn Ltd (GUJTHEM) as of 17-Apr-2026 is 12.57.

What is the 52-week high and low of Gujarat Themis Biosyn Ltd (GUJTHEM)?

The 52-week high of Gujarat Themis Biosyn Ltd (GUJTHEM) is Rs. 479.45 and the 52-week low is Rs. 225.75.

What is the TTM revenue of Gujarat Themis Biosyn Ltd (GUJTHEM)?

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Gujarat Themis Biosyn is Rs. 159.33 (Cr.).

Gujarat Themis Biosyn Ltd (GUJTHEM) Share Analysis – Quality, Pipeline & Valuation Zone & DeciZen Rating

Name: Gujarat Themis Biosyn Ltd (GUJTHEM)
Brand: Gujarat Themis Biosyn

10 Year X-Ray :

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
ROCE % ⓘ	80.4%	54.7%	42.2%	44.9%	86%	67.9%	67.9%	61.5%	45.4%	27.5%	-
Value Creation Index ⓘ	4.7	2.9	2.0	2.2	5.1	3.9	3.9	3.4	2.2	1.0	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	32.6	35.7	38.8	41.1	85.1	90.6	115	148	170	151	159
Sales YoY Gr.	-	9.4%	8.7%	5.8%	107.4%	6.4%	26.8%	29.2%	14.4%	-11.2%	-
Adj EPS ⓘ	0.4	0.4	0.4	0.6	2.2	2.8	4	5.3	5.4	4.5	4.4
YoY Gr.	-	-4.8%	-10%	61.1%	274.1%	27.7%	44.4%	33%	2.1%	-17.7%	-
BVPS (₹) ⓘ	0.4	0.8	1.1	1.7	3.9	6.4	9.5	13.7	18.5	22.8	25.4
Adj Net Profit ⓘ	4.6	4.4	3.9	6.4	23.7	30.2	43.6	58	59.2	48.7	48
Cash Flow from Ops. ⓘ	3.9	2.8	5.6	0.7	0.6	10.5	40.3	39.5	64.2	91	-
Debt/CF from Ops. ⓘ	0.9	1.4	0.1	8.8	12.9	0.3	0	0	0	0.3	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	18.5%	12.1%	9.5%	-11.2%
Adj EPS ⓘ	30.1%	15.6%	3.8%	-17.7%
BVPSⓘ	59%	42.6%	34%	23.3%
Share Price	46.9%	63%	48.8%	1%

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
Return on Equity % ⓘ	302.7	72.5	38.1	41.6	78	53.8	50.4	45.9	33.8	21.7	18.2
Op. Profit Mgn % ⓘ	18.5	17	16.1	17.9	37.4	44.5	50.5	49.6	46.4	45.7	45.3
Net Profit Mgn % ⓘ	14.2	12.2	10	15.5	27.8	33.3	38	39.1	34.9	32.3	30
Debt to Equity ⓘ	0.9	0.5	0.1	0.3	0.2	0	0	0	0	0.1	-
Working Cap Days ⓘ	55	78	73	92	144	204	226	267	245	222	60
Cash Conv. Cycle ⓘ	-47	-26	-22	-19	27	54	62	47	24	26	28

Recent Performance Summary

No data to display

Return on Equity has declined versus last 3 years average to 18.20%

Sales growth has been subdued in last 3 years 9.50%

Net Profit has been subdued in last 3 years 3.77%

Sales growth is not so good in last 4 quarters at 3.49%

	Standalone	Consolidated
TTM EPS (₹)	4.4	-
TTM Sales (₹ Cr.)	159	-
BVPS (₹) ⓘ	25.4	-
Reserves (₹ Cr.) ⓘ	266	-
P/BV ⓘ	12.57	-
PE ⓘ	72.84	-

From the Market
52 Week Low / High (₹)	225.75 / 479.45
All Time Low / High (₹)	0.20 / 479.45
Market Cap (₹ Cr.)	3,481
Equity (₹ Cr.)	10.9
Face Value (₹)	1
Industry PE ⓘ	42.1

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Sales	33	36	39	41	85	91	115	148	170	151
Operating Expenses ⓘ +	27	30	33	34	53	50	57	75	91	82
Manufacturing Costs	21	23	25	26	34	26	31	37	40	40
Material Costs	0	1	2	1	11	15	16	26	36	23
Employee Cost	4	4	4	5	6	7	7	8	10	11
Other Costs ⓘ	1	1	2	2	2	2	3	4	5	8
Operating Profit ⓘ	6	6	6	7	32	40	58	74	79	69
Operating Profit Margin (%)	18.5%	16.9%	16.1%	17.9%	37.4%	44.5%	50.5%	49.6%	46.4%	45.7%
Other Income ⓘ +	0	0	0	2	2	3	4	7	4	2
Exceptional Items ⓘ	0	0	0	0	0	0	0	0	0	0
Interest ⓘ	0	0	0	0	1	1	1	0	0	0
Depreciation ⓘ	1	1	1	1	1	2	2	3	4	5
Profit Before Tax ⓘ	5	5	5	8	31	41	59	77	79	66
Tax ⓘ	0	1	1	2	8	11	15	19	20	17
Profit After Tax	5	4	4	6	24	30	44	58	59	49
PAT Margin (%)	14.2%	12.3%	10.0%	15.6%	27.8%	33.3%	38.0%	39.1%	34.8%	32.3%
Adjusted EPS (₹)	0.4	0.4	0.4	0.6	2.2	2.8	4.0	5.3	5.4	4.5
Dividend Payout Ratio (%)	0%	0%	0%	0%	10%	0%	37%	14%	12%	15%

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Equity and Liabilities
Shareholders Fund +	4	8	12	19	42	70	103	149	201	248
Share Capital ⓘ	7	7	7	7	7	7	7	7	7	11
Reserves ⓘ	-3	1	5	11	35	63	96	142	194	237
Debt +	1	2	0	0	3	0	0	0	0	30
Long Term Debt	1	1	0	0	3	0	0	0	0	30
Short Term Debt	0	1	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0
Trade Payables	6	7	6	6	7	4	7	10	10	15
Others Liabilities ⓘ	4	4	3	9	18	25	27	28	30	25
Total Liabilities ⓘ	15	21	20	33	71	98	137	187	241	318
Fixed Assets
Net Fixed Assets ⓘ +	9	11	11	15	17	19	19	33	38	41
Gross Block	42	12	13	18	22	26	28	44	51	59
Accumulated Depreciation	32	1	2	3	5	7	9	11	13	18
CWIP ⓘ	0	0	0	1	0	2	13	21	91	184
Investments ⓘ	0	0	0	0	0	0	0	0	0	0
Inventories	0	1	0	0	6	6	12	15	3	5
Trade Receivables	2	7	3	6	20	15	25	18	27	31
Cash Equivalents	0	0	4	2	2	28	12	9	8	13
Others Assets ⓘ	2	3	2	9	25	29	56	92	73	43
Total Assets ⓘ	15	21	20	33	71	98	137	187	241	318

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Cash Flow From Operating Activity ⓘ +	4	3	6	1	1	11	40	39	64	91
PBT ⓘ	5	5	5	8	31	41	59	77	79	66
Adjustment ⓘ	2	1	1	-4	1	-0	0	-2	0	5
Changes in Working Capital ⓘ	-2	-3	-0	-2	-24	-20	-4	-15	4	37
Tax Paid ⓘ	-1	-1	-1	-1	-7	-10	-15	-20	-20	-16
Cash Flow From Investing Activity ⓘ +	-1	-3	-1	-6	-3	-2	-30	-20	-55	-112
Capex	-1	-3	-1	-6	-3	-3	-14	-24	-75	-116
Net Investments	-0	0	0	0	0	0	0	0	0	0
Others ⓘ	0	0	0	0	0	1	-16	3	19	4
Cash Flow From Financing Activity ⓘ +	-3	-0	-4	5	2	-5	-14	-13	-9	26
Net Proceeds from Shares ⓘ	0	0	0	0	0	0	0	0	0	0
Net Proceeds from Borrowing ⓘ	-4	0	0	0	0	0	0	0	0	30
Interest Paid ⓘ	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0
Dividend Paid ⓘ	0	0	0	0	0	-2	-10	-12	-7	-2
Others ⓘ	1	0	-4	5	2	-2	-4	-1	-2	-1
Net Cash Flow ⓘ	-0	0	1	0	-0	3	-4	6	0	5

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Ratios
ROE (%)	302.71	72.63	38.06	41.85	77.99	53.82	50.35	45.92	33.76	21.69
ROCE (%)	80.38	54.67	42.22	44.88	85.96	67.89	67.91	61.51	45.4	27.48
Asset Turnover Ratio	2.22	1.98	1.85	1.54	1.64	1.07	0.98	0.92	0.79	0.54
PAT to CFO Conversion(x)	0.8	0.75	1.5	0.17	0.04	0.37	0.91	0.67	1.08	1.86
Working Capital Days
Receivable Days	25	47	46	38	56	70	63	53	48	71
Inventory Days	4	5	5	4	14	24	28	32	19	10
Payable Days	0	2,000	1,309	2,104	215	133	115	114	99	193

About Gujarat Themis Biosyn Ltd

Gujarat Themis Biosyn Ltd, established in 1981, is a biotech and synthetic product manufacturing company, having plants at Vapi, Hyderabad, with group turnover of over $ 40 million. It has EDMFs, available and WHO approved plants.

The company has world-wide exports to satisfied customers, having customised facility for all products.

The companyâ€™s principal activity is to manufacture and distributes pharmaceuticals bulk drugs called rifampicin produced by fermentation process. The company's products include preparations of active pharmaceutical ingredient rifampicin and lovastatin. The company exports its products to Europe and the United States.

Kopran alongwith Cadila Healthcare Ltd., Lyka Labs Ltd., Themis Chemicals Ltd. and Anant & Co., formed Pharmaceutical Business Group (India) Ltd. in 1990.PBG acquired Gujarat Themis Biosyn Ltd (GTBL) as a sick company from BIFR in collaboration with Yuhan Corporation, South Korea and became Indiaâ€™s first producer of Rifampicin.Yuhan has provided technology for Rifampicin from fermentation and invested in equity also.

Business area of the company

Pharmaceuticals & Drugs

Build a Stress-Tested Portfolio.

Our Sapphire Advisory uses the ABC Concept to ensure you never have to panic during a market correction.

Core Stocks

STABILITY

Booster Stocks

GROWTH

Amplifier Stocks

ASYMMETRY

● Conflict-Free ● SEBI Registered ● 15Y+ Track Record

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Gujarat Themis Biosyn Ltd (GUJTHEM) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

Guj. Themis Biosyn Share Price